FDA staff argue AI hallucinations can be minimized, but only at a cost | BioWorld
A team of five members of the U.S. FDA staff published a review of the use of AI in health care and concluded that while hallucinations in AI ...
Read the original at BioWorld ↗
- Topics
- Hallucinations & FabricationHealthcareMedia & Creative Work
- Mentions
- FDAUnited States
- Tracked via
- “AI hallucination”